Effects of the Novel Long-Acting GLP-1 Agonist, Albiglutide, on Cardiac Function, Cardiac Metabolism, and Exercise Capacity in Patients With Chronic Heart Failure and Reduced Ejection Fraction

Authors: John J. Lepore, Eric J. Olson, Laura A. Demopoulos, Thomas Haws, Zixing Fang, April Barbour, Michael J. Fossler, Víctor G. Dávila‐Román, Stuart D. Russell, Robert J. Gropler - JACC Heart Failure 2016 cited by 171